|4Jun 4, 11:53 AM ET

VioQuest Pharmaceuticals, Inc. 4

4 · VioQuest Pharmaceuticals, Inc. · Filed Jun 4, 2013

Insider Transaction Report

Form 4
Period: 2013-05-31
DACKO MARK D
DirectorCFO and Secretary
Transactions
  • Award

    Stock Options (right to buy)

    2013-05-31+500,000500,000 total
    Exercise: $0.02From: 2013-05-31Exp: 2023-05-31Common Stock (500,000 underlying)
Holdings
  • Common Stock

    0

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -